Five projects vie to become Brazil’s first national vaccine against Covid-19
RIO DE JANEIRO, BRAZIL - Butanvac, which is being developed at the Butantan Institute and is already being tested in...
August 14, 2021Topic
Anvisa
Pfizer asks Brazil’s health regulator for emergency use of drug for complications of Covid
Pfizer says it has requested to the National Health Regulator (Anvisa) the emergency use of the drug tofacitinib to treat...
July 28, 2021
Glaxo asks Brazil’s health regulator for emergency use of Sotrovimab Covid-19 drug
RIO DE JANEIRO, BRAZIL - The National Health Regulatory Agency (Anvisa) received, on Monday (19), a request for emergency use...
July 19, 2021
Anvisa authorizes phase 3 clinical trial with proxalutamide for treatment of Covid-19
RIO DE JANEIRO, BRAZIL - Brazil's national health regulatory agency Anvisa authorized on Monday, 19, a clinical trial to evaluate...
July 19, 2021
Who is Roberto Ferreira Dias, arrested during Brazil’s Covid CPI session?
RIO DE JANEIRO, BRAZIL - The Covid CPI (Parliamentary Inquiry Commission) on Wednesday, July 7, heard testimony from the Ministry...
July 8, 2021
ANVISA receives request for emergency use of Covaxin, the Indian Covid-19 vaccine
The National Health Surveillance Agency (Anvisa) announced that on Tuesday morning (29) it received the request for emergency use of...
June 29, 2021
Brazil’s health regulator denies approval of Avifavir, Russian antiviral against Covid-19
According to the vote of Director Meiruze Freitas, the drug does not meet the health regulator Anvisa's expectations in terms...
June 22, 2021
ANVISA warns of risks of indiscriminate use of paracetamol after Covid-19 vaccination
The indiscriminate use of paracetamol for pain and fever relief after Covid-19 vaccination can lead to serious adverse events, including...
May 28, 2021
Brazil’s health regulator grants Fiocruz approval to produce cannabidiol
Fiocruz's Institute of Technology in Pharmaceuticals was granted on Thursday the last approval by the Brazilian Health Regulatory Agency (ANVISA)...
May 14, 2021